Actively Recruiting
Prognostic Impact of the Location of Mitral Valve Prolapse on the Long-term Results of Mitral Plasty
Led by Centre Hospitalier Universitaire, Amiens · Updated on 2023-05-23
1500
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Mitral insufficiency (MI) is a common heart valve problem that affects many adults, especially those over 75 years old. It is a leading cause of valve disease in Europe, often caused by mitral valve prolapse. This research observes how the location of mitral valve prolapse influences the long-term results after mitral valve repair surgery, which is the standard treatment for symptomatic MI. The study follows patients who underwent mitral valve surgery between 1988 and 2011. It investigates how the site of the prolapse—whether affecting one or both leaflets of the mitral valve—may impact surgical outcomes over time. The research collects data from clinical evaluations and echocardiography performed when the patients were initially diagnosed. Participants are monitored for survival, measured from the date of surgery until death or the last known follow-up within six months. The study assesses long-term outcomes based on valve geometry and prolapse location. No new treatments are given, and the study mainly involves reviewing past surgery cases and clinical records to understand prognosis.
CONDITIONS
Brief Title
Prognostic Impact of the Location of Mitral Valve Prolapse on the Long-term Results of Mitral Plasty
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients operated between 1988 and 2011
- Presence of a valvular prolapse diagnosed by echocardiography
- Possibility of a complete clinical evaluation at the time of the initial echocardiography
- Age 18 years or older
You will not qualify if you...
- Ischemic mitral insufficiency, including papillary muscle rupture
- Significant aortic valvulopathy, mitral valvular stenosis, or congenital heart disease
- History of cardiac surgery other than mitral valve repair
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 6 months after surgery
Participants who underwent mitral valve surgery are observed to assess survival and health outcomes over time.
Follow-up visits as scheduled based on clinical care
Trial Site Locations
Total: 1 location
1
CHU Amiens Picardie
Amiens, Picardie, France, 80054
Actively Recruiting
Research Team
C
Catherine SZYMANSKI, Dr
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here